The $2 Billion Question Behind Kalshi’s New Prediction Market

Kalshi's new prediction market aims to revolutionize drug development by offering a platform where investors can bet on clinical trial outcomes, potentially accelerating the process and directing funding toward promising treatments. Experts argue it could steer investments toward projects with higher perceived success rates, which may overlook less flashy but potentially groundbreaking research. While the market promises efficiency, there's concern it could distort the scientific landscape by prioritizing financial gains over comprehensive medical progress. This innovation underscores a broader debate about how to balance investment incentives with scientific integrity in healthcare research.